Veenstra, David L.; Sullivan, Sean D.; Clarke, Lauren; … - In: PharmacoEconomics 25 (2007) 11, pp. 963-977
B (CHB) with entecavir compared with lamivudine with adefovir salvage, based primarily on the results of a recent 2-year … clinical data for entecavir and lamivudine beyond 1-year duration and for salvage therapy. Methods: We conducted a cost …-old patients with HBeAg-positive CHB. We evaluated 2 years of treatment with entecavir 0.5mg/day versus lamivudine 100mg/day, plus …